Point72 Hong Kong LTD Prelude Therapeutics Inc Transaction History

Point72 Hong Kong LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$6.9 - $13.22 $26,716 - $51,187	-3,872 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$11.89 - $31.74 $26,990 - $72,049	2,270 Added 141.7%	3,872 $48,000
Q3 2021 Nov 15, 2021	BUY	$25.78 - $38.65 $41,299 - $61,917	1,602 New	1,602 $50,000
Q4 2020 Feb 16, 2021	SELL	$28.81 - $88.94 $180,091 - $555,963	-6,251 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$26.2 - $30.13 $163,776 - $188,342	6,251 New	6,251 $188,000

35.7M

500

300

Ticker PRLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,369,200
Market Cap $34.6M
Description
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.